相似文献
1
Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review.
Cancer Biol Ther. 2017 Sep 2;18(9):635-639. doi: 10.1080/15384047.2017.1345394. Epub 2017 Jul 5.
2
Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report.
Medicine (Baltimore). 2016 Aug;95(31):e4368. doi: 10.1097/MD.0000000000004368.
3
Successful treatment using apatinib in intractable brain edema: A case report and literatures review.
Cancer Biol Ther. 2018;19(12):1093-1096. doi: 10.1080/15384047.2018.1491502. Epub 2018 Aug 6.
4
Effective treatment of apatinib in desmoplastic small round cell tumor: a case report and literature review.
BMC Cancer. 2018 Mar 27;18(1):338. doi: 10.1186/s12885-018-4135-x.
5
Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China.
BMC Cancer. 2018 Apr 6;18(1):396. doi: 10.1186/s12885-018-4303-z.
6
Evaluation of efficacy and safety of apatinib treatment in advanced gastric cancer.
J Cancer Res Ther. 2019;15(2):365-369. doi: 10.4103/jcrt.JCRT_297_18.
7
Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review.
World J Gastroenterol. 2017 Nov 7;23(41):7478-7488. doi: 10.3748/wjg.v23.i41.7478.
8
The efficacy and safety of low-dose Apatinib in the management of stage IV luminal-type breast cancer: a case report and literature review.
Anticancer Drugs. 2021 Sep 1;32(8):773-778. doi: 10.1097/CAD.0000000000001102.
9
Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non-small cell lung cancer after second-line chemotherapy treatment: A retrospective study.
Thorac Cancer. 2018 Dec;9(12):1754-1762. doi: 10.1111/1759-7714.12898. Epub 2018 Oct 19.
10
Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers.
Drugs. 2018 May;78(7):747-758. doi: 10.1007/s40265-018-0903-9.
引用本文的文献
1
Pancreatic liposarcoma: A case series and literature overview of an extremely rare soft tissue tumor.
Int J Surg Case Rep. 2025 Jul 18;134:111699. doi: 10.1016/j.ijscr.2025.111699.
2
Pancreatic liposarcoma: A case report.
Oncol Lett. 2025 Apr 7;29(6):268. doi: 10.3892/ol.2025.15014. eCollection 2025 Jun.
3
Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine guidelines: Rare pancreatic tumors, ultrasound and contrast-enhanced ultrasound features-Malignant mesenchymal tumors.
Endosc Ultrasound. 2024 Mar-Apr;13(2):55-64. doi: 10.1097/eus.0000000000000054. Epub 2024 Apr 19.
4
Primary Pancreatic Liposarcoma: An Unexpected Cause of a Pancreatic Mass.
ACG Case Rep J. 2023 Dec 15;10(12):e01242. doi: 10.14309/crj.0000000000001242. eCollection 2023 Dec.
5
Pancreatic liposarcoma: a case report.
Abdom Radiol (NY). 2022 Jun;47(6):1912-1916. doi: 10.1007/s00261-022-03522-4. Epub 2022 May 4.
6
Huge primary dedifferentiated pancreatic liposarcoma mimicking carcinosarcoma in a young female: A case report.
World J Clin Cases. 2019 Jun 6;7(11):1344-1350. doi: 10.12998/wjcc.v7.i11.1344.
7
Apatinib monotherapy for advanced VEGFR-2-negative nasopharyngeal carcinoma: A case report.
Medicine (Baltimore). 2019 Jan;98(1):e13491. doi: 10.1097/MD.0000000000013491.
8
The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study.
Cancer Biol Ther. 2019;20(3):321-327. doi: 10.1080/15384047.2018.1529099. Epub 2018 Oct 17.
9
Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study.
Cancer Biol Ther. 2018 Mar 4;19(3):198-204. doi: 10.1080/15384047.2017.1416275. Epub 2018 Jan 24.
本文引用的文献
1
Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China.
Oncotarget. 2017 Mar 16;8(38):64471-64480. doi: 10.18632/oncotarget.16293. eCollection 2017 Sep 8.
2
HIF-1α, MDM2, CDK4, and p16 expression in ischemic fasciitis, focusing on its ischemic condition.
Virchows Arch. 2017 Jul;471(1):117-122. doi: 10.1007/s00428-017-2122-2. Epub 2017 May 6.
3
Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer.
Oncotarget. 2017 Feb 14;8(7):11990-12002. doi: 10.18632/oncotarget.14467.
4
Successful treatment of advanced malignant fibrous histiocytoma of the right forearm with apatinib: a case report.
Onco Targets Ther. 2016 Feb 5;9:643-7. doi: 10.2147/OTT.S96133. eCollection 2016.
5
A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup.
Jpn J Clin Oncol. 2016 Mar;46(3):248-53. doi: 10.1093/jjco/hyv184. Epub 2016 Feb 10.
6
Apatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumors.
Drugs Today (Barc). 2015 Apr;51(4):223-9. doi: 10.1358/dot.2015.51.4.2320599.
7
Surgical treatment of retroperitoneal liposarcoma.
Yonago Acta Med. 2014 Dec;57(4):129-32. Epub 2014 Dec 26.
8
Giant retroperitoneal liposarcoma: Case report and review of the literature.
Int J Surg Case Rep. 2015;9:23-6. doi: 10.1016/j.ijscr.2015.02.019. Epub 2015 Feb 17.
9
Advances in the targeted therapy of liposarcoma.
Onco Targets Ther. 2015 Jan 5;8:125-36. doi: 10.2147/OTT.S72722. eCollection 2015.
10
Lessons learned from the study of 10,000 patients with soft tissue sarcoma.
Ann Surg. 2014 Sep;260(3):416-21; discussion 421-2. doi: 10.1097/SLA.0000000000000869.
Zotero 插件